SG11201608658SA - Novel manufacturing process for triazine, pyrimidine and pyridine derivatives - Google Patents
Novel manufacturing process for triazine, pyrimidine and pyridine derivativesInfo
- Publication number
- SG11201608658SA SG11201608658SA SG11201608658SA SG11201608658SA SG11201608658SA SG 11201608658S A SG11201608658S A SG 11201608658SA SG 11201608658S A SG11201608658S A SG 11201608658SA SG 11201608658S A SG11201608658S A SG 11201608658SA SG 11201608658S A SG11201608658S A SG 11201608658SA
- Authority
- SG
- Singapore
- Prior art keywords
- triazine
- pyrimidine
- manufacturing process
- pyridine derivatives
- novel manufacturing
- Prior art date
Links
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 title 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/127—Preparation from compounds containing pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/44—One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14165418 | 2014-04-22 | ||
| PCT/EP2015/058493 WO2015162084A1 (en) | 2014-04-22 | 2015-04-20 | Novel manufacturing process for triazine, pyrimidine and pyridine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201608658SA true SG11201608658SA (en) | 2016-11-29 |
Family
ID=50489013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608658SA SG11201608658SA (en) | 2014-04-22 | 2015-04-20 | Novel manufacturing process for triazine, pyrimidine and pyridine derivatives |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10100031B2 (en) |
| EP (1) | EP3134388B1 (en) |
| JP (1) | JP6513105B2 (en) |
| KR (1) | KR102472711B1 (en) |
| CN (1) | CN106458968B (en) |
| AU (1) | AU2015250994B2 (en) |
| BR (1) | BR112016023811B8 (en) |
| CA (1) | CA2944697C (en) |
| ES (1) | ES2713452T3 (en) |
| IL (1) | IL248272B (en) |
| RU (1) | RU2688665C2 (en) |
| SG (1) | SG11201608658SA (en) |
| WO (1) | WO2015162084A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10993947B2 (en) * | 2016-05-18 | 2021-05-04 | Torqur | Treatment of skin lesions |
| CN107793394A (en) * | 2017-08-03 | 2018-03-13 | 上海厚璞生物科技有限公司 | A kind of serial key intermediate for producing selective PI3K inhibitor |
| WO2019101853A1 (en) | 2017-11-23 | 2019-05-31 | Piqur Therapeutics Ag | Treatment of skin disorders |
| CN110204529A (en) * | 2018-02-28 | 2019-09-06 | 朱允涛 | A kind of preparation method and purposes of deuterated compound in triazine class |
| ES3032793T3 (en) * | 2018-04-10 | 2025-07-24 | Neuropore Therapies Inc | Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathways |
| AU2021242143B2 (en) * | 2020-03-27 | 2024-07-18 | Dong-A St Co., Ltd. | Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3707725A (en) | 1970-06-19 | 1972-12-26 | Ibm | Program execution tracing system improvements |
| US4727145A (en) | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
| CO5271680A1 (en) | 2000-02-21 | 2003-04-30 | Smithkline Beecham Corp | COMPOUNDS |
| GB0027987D0 (en) | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
| GB0127433D0 (en) | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
| BRPI0616571A2 (en) | 2005-09-27 | 2011-06-21 | Hoffmann La Roche | oxadiazolyl pyrazol pyridimines as mglur2 antagonists, process for their preparation, pharmaceutical composition containing them and use thereof |
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | PI-3 Kinase inhibitors and methods of their use |
| CA2691448A1 (en) | 2007-08-31 | 2009-03-05 | Dominique Swinnen | Triazolopyridine compounds and their use as ask inhibitors |
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| JP5589003B2 (en) | 2009-02-04 | 2014-09-10 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | Derivatives of [1,3] oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders |
| WO2011109932A1 (en) * | 2010-03-09 | 2011-09-15 | F.Hoffmann-La Roche Ag | Novel process for the manufacture of 5-halogenated-7-azaindoles |
| RU2015150728A (en) * | 2010-10-01 | 2019-01-15 | Новартис Аг | METHOD FOR PRODUCING PYRIMIDINE DERIVATIVES |
| WO2012109423A1 (en) * | 2011-02-11 | 2012-08-16 | Dana-Farber Cancer Institute, Inc. | Method of inhibiting hamartoma tumor cells |
| USRE47689E1 (en) | 2011-12-30 | 2019-11-05 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| CN103214481B (en) | 2012-01-21 | 2016-08-03 | 中国科学院上海药物研究所 | Novel imidazole also [1,2-a] pyridine compounds and their, its preparation method, comprise the medical composition and its use of this compounds |
| CN104619709B (en) | 2012-07-13 | 2016-11-09 | Ucb生物制药私人有限公司 | Imidazolopyridine Derivatives as TNF Activity Modulators |
| CN104837832B (en) | 2012-10-05 | 2019-04-26 | 里格尔药品股份有限公司 | GDF-8 inhibitors |
| CN104736532B (en) | 2012-10-23 | 2017-04-05 | 诺华股份有限公司 | The method of improved production 5 (2,6 24 morpholine, 4 pyrimidine) 4 trifluoromethyl pyridine, 2 amine |
| GB201321736D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
-
2015
- 2015-04-20 SG SG11201608658SA patent/SG11201608658SA/en unknown
- 2015-04-20 CN CN201580020864.2A patent/CN106458968B/en active Active
- 2015-04-20 ES ES15720631T patent/ES2713452T3/en active Active
- 2015-04-20 US US15/304,595 patent/US10100031B2/en active Active
- 2015-04-20 WO PCT/EP2015/058493 patent/WO2015162084A1/en not_active Ceased
- 2015-04-20 EP EP15720631.9A patent/EP3134388B1/en active Active
- 2015-04-20 RU RU2016138800A patent/RU2688665C2/en active
- 2015-04-20 BR BR112016023811A patent/BR112016023811B8/en active IP Right Grant
- 2015-04-20 AU AU2015250994A patent/AU2015250994B2/en active Active
- 2015-04-20 JP JP2016564058A patent/JP6513105B2/en active Active
- 2015-04-20 KR KR1020167030308A patent/KR102472711B1/en active Active
- 2015-04-20 CA CA2944697A patent/CA2944697C/en active Active
-
2016
- 2016-10-09 IL IL248272A patent/IL248272B/en active IP Right Grant
-
2018
- 2018-07-25 US US16/045,427 patent/US10766874B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190016698A1 (en) | 2019-01-17 |
| EP3134388A1 (en) | 2017-03-01 |
| CA2944697A1 (en) | 2015-10-29 |
| KR102472711B1 (en) | 2022-12-01 |
| AU2015250994A1 (en) | 2016-11-03 |
| BR112016023811B1 (en) | 2022-06-28 |
| BR112016023811B8 (en) | 2023-01-10 |
| RU2688665C2 (en) | 2019-05-22 |
| RU2016138800A (en) | 2018-05-22 |
| US10100031B2 (en) | 2018-10-16 |
| US10766874B2 (en) | 2020-09-08 |
| IL248272B (en) | 2020-03-31 |
| IL248272A0 (en) | 2016-11-30 |
| RU2016138800A3 (en) | 2018-10-19 |
| KR20160144402A (en) | 2016-12-16 |
| WO2015162084A1 (en) | 2015-10-29 |
| ES2713452T3 (en) | 2019-05-21 |
| CN106458968B (en) | 2019-06-25 |
| JP6513105B2 (en) | 2019-05-15 |
| AU2015250994B2 (en) | 2018-12-20 |
| JP2017513888A (en) | 2017-06-01 |
| US20170037027A1 (en) | 2017-02-09 |
| EP3134388B1 (en) | 2019-01-09 |
| CN106458968A (en) | 2017-02-22 |
| BR112016023811A2 (en) | 2017-08-15 |
| CA2944697C (en) | 2022-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286165B1 (en) | Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereof | |
| IL259169A (en) | Novel pyrazolo pyrimidine derivatives | |
| IL251126A0 (en) | Process for manufacturing pyrimidine sulfamide derivatives | |
| PL3345877T3 (en) | Method for manufacturing glass plate, glass plate, method for manufacturing glass article, glass article | |
| IL248272A0 (en) | Novel manufacturing process for triazine, pyrimidine and pyridine derivatives | |
| IL242460A (en) | Process for preparing 4,6-bis(aryloxy)pyrimidine derivatives | |
| PL3160985T3 (en) | Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide | |
| SG11201803357TA (en) | Pyrimidine derivative | |
| IL252945B (en) | Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives | |
| IL259360B (en) | Diamino pyridine derivatives | |
| GB2555726B (en) | Urea production method | |
| SG11201701075UA (en) | Method for producing dip-formed article, and dip-formed article | |
| IL249210A0 (en) | Pyridine derivative | |
| PT3228616T (en) | Pyridine derivatives | |
| GB201615769D0 (en) | 5-(Trifluoromethyl) Pyrimidine derivative and production method therefor | |
| EP3099666A4 (en) | Process for making 2-chloro-5-methylpyridine | |
| HK1232523A1 (en) | Process for manufacturing pyrimidine sulfamide derivatives | |
| HK1232523B (en) | Process for manufacturing pyrimidine sulfamide derivatives |